Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Fleck PR"'
Autor:
White, WB, Cannon, CP, Heller, SR, Nissen, SE, Bergenstal, RM, Bakris, GL, Perez, AT, Fleck, PR, Mehta, CR, Kupfer, S, Wilson, C, Cushman, WC Zannad, F, Knežević, Aleksandar
To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic therapies. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::2e61a0fb17236c3e4bc69cb06ca7934a
https://www.bib.irb.hr/736879
https://www.bib.irb.hr/736879
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current Medical Research & Opinion; Jan2009, Vol. 25 Issue 10, p2361-2371, 11p
Autor:
Rosenstock J, Inzucchi SE, Seufert J, Fleck PR, Wilson CA, Mekki Q, Rosenstock, Julio, Inzucchi, Silvio E, Seufert, Jochen, Fleck, Penny R, Wilson, Craig A, Mekki, Qais
Publikováno v:
Diabetes Care; Nov2010, Vol. 33 Issue 11, p2406-2408, 3p
Autor:
DeFronzo RA, Fleck PR, Wilson CA, Mekki Q, Alogliptin Study 010 Group, DeFronzo, Ralph A, Fleck, Penny R, Wilson, Craig A, Mekki, Qais
Publikováno v:
Diabetes Care; Dec2008, Vol. 31 Issue 12, p2315-2317, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
White, W., Cannon, C., Heller, S., Nissen, S., Bergenstal, R., Bakris, G., Perez, A., Fleck, P., Mehta, C., Kupfer, S., Wilson, C., Cushman, W., Zannad, F., Novo, S.
BACKGROUND: To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44879c6e6bd7a36a3d5335e572c14d1f
http://hdl.handle.net/10447/94479
http://hdl.handle.net/10447/94479
Autor:
Michaelides M; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK. Electronic address: michel.michaelides@ucl.ac.uk., Besirli CG; Kellogg Eye Center (C.G.B.), Ann Arbor, Michigan, USA; Janssen Pharmaceuticals (C.G.B.), Raritan, New Jersey, USA., Yang Y; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK., DE Guimaraes TAC; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK., Wong SC; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust (S.C.W.), London, UK., Huckfeldt RM; Ocular Genomics Institute, Massachusetts Eye and Ear, Harvard Medical School (R.M.H., J.I.C.), Boston, Massachusetts, USA., Comander JI; Ocular Genomics Institute, Massachusetts Eye and Ear, Harvard Medical School (R.M.H., J.I.C.), Boston, Massachusetts, USA., Sahel JA; UPMC Eye Center, University of Pittsburgh School of Medicine (J.-A.S., S.M.S.), Pittsburgh, Pennsylvania, USA., Shah SM; UPMC Eye Center, University of Pittsburgh School of Medicine (J.-A.S., S.M.S.), Pittsburgh, Pennsylvania, USA; Gundersen Health System (S.M.S., R.R.A.), La Crosse, Wisconsin, USA., Tee JJL; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK., Kumaran N; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK; Guy's and St. Thomas' NHS Foundation Trust (N.K.), London, UK., Georgiadis A; MeiraGTx (A.G., R.Z., S.N., A.F.), New York, New York, USA., Minnick P; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Zeldin R; MeiraGTx (A.G., R.Z., S.N., A.F.), New York, New York, USA., Naylor S; MeiraGTx (A.G., R.Z., S.N., A.F.), New York, New York, USA., Xu J; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Clark M; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Anglade E; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Wong P; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Fleck PR; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Fung A; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Peluso C; Janssen Pharmaceuticals (P.M., J.X., M.C., E.A., P.W., P.R.F., A.F., C.P.), Raritan, New Jersey, USA., Kalitzeos A; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK., Georgiou M; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK; Jones Eye Institute, University of Arkansas for Medical Sciences (M.G.), Little Rock, Arkansas, USA., Ripamonti C; Cambridge Research Systems Ltd. (C.R.), Rochester, UK., Smith AJ; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Centre for Gene Therapy and Regenerative Medicine, King's College London (A.J.S.), London, UK., Ali RR; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Gundersen Health System (S.M.S., R.R.A.), La Crosse, Wisconsin, USA., Forbes A; MeiraGTx (A.G., R.Z., S.N., A.F.), New York, New York, USA., Bainbridge J; From the UCL Institute of Ophthalmology (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., A.K., M.G., A.J.S., R.R.A., J.B.), London, UK; Moorfields Eye Hospital NHS Foundation Trust (M.M., Y.Y., T.A.C.G., S.C.W., J.J.L.T., N.K., A.K., M.G., J.B.), London, UK.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2024 Jun 12; Vol. 267, pp. 122-134. Date of Electronic Publication: 2024 Jun 12.
Autor:
White WB; University of Connecticut School of Medicine, Farmington, CT wwhite@uchc.edu., Kupfer S; Takeda Development Center Americas, Inc., Deerfield, IL., Zannad F; INSERM 9501, Universite de Lorraine and CHU, Nancy, France., Mehta CR; Harvard School of Public Health, Boston, MA., Wilson CA; Takeda Development Center Americas, Inc., Deerfield, IL., Lei L; Harvard Clinical Research Institute, Boston, MA., Bakris GL; The University of Chicago Medicine, Chicago, IL., Nissen SE; Cleveland Clinic Foundation, Cleveland, OH., Cushman WC; The University of Tennessee Health Science Center College of Medicine, Memphis VA Medical Center, Memphis, TN., Heller SR; University of Sheffield, Sheffield, U.K., Bergenstal RM; International Diabetes Center, Park-Nicollet Clinic, Minneapolis, MN., Fleck PR; Takeda Development Center Americas, Inc., Deerfield, IL., Cannon CP; Harvard Clinical Research Institute, Boston, MA Harvard Medical School, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2016 Jul; Vol. 39 (7), pp. 1267-73. Date of Electronic Publication: 2016 Jun 11.
Autor:
Zannad F; Institut Lorrain du Coeur et des Vaisseaux, Centre d'Investigation Clinique Inserm, Université de Lorraine and CHU, Vandoeuvre-Les-Nancy, France. Electronic address: f.zannad@chu-nancy.fr., Cannon CP; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Cushman WC; University of Tennessee College of Medicine, Memphis Veterans Affairs Medical Center, Memphis, TN, USA., Bakris GL; University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Menon V; Cleveland Clinic Foundation, Cleveland, OH, USA., Perez AT; Takeda Development Center Americas, Deerfield, IL, USA., Fleck PR; Takeda Development Center Americas, Deerfield, IL, USA., Mehta CR; Harvard School of Public Health, Boston, MA, USA., Kupfer S; Takeda Development Center Americas, Deerfield, IL, USA., Wilson C; Takeda Development Center Americas, Deerfield, IL, USA., Lam H; Takeda Development Center Americas, Deerfield, IL, USA., White WB; Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2015 May 23; Vol. 385 (9982), pp. 2067-76. Date of Electronic Publication: 2015 Mar 10.